Keywords: merck, kgaa, sees, positive, erbitux, data, german

Merck KGaA sees positive Erbitux data

Article | 13 November 2006

Print This

German drugmaker Merck KGaAsays that the results of a Phase III study of Erbitux (cetuximab), used with irinotecan as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in